Harriet de Wit
Directeur/Membre du Conseil chez PHARMALA BIOTECH HOLDINGS INC.
Fortune : 8 300 $ au 30/06/2024
Profil
Harriet de Wit is currently a Director at Pharmala Biotech Holdings, Inc. and Pharmala Biotech, Inc. She is also a Professor at The University of Chicago.
She received her doctorate degree from Concordia University in 1981 and her undergraduate degree from the University of Calgary.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/02/2024 | 100 000 ( 0,11% ) | 8 300 $ | 30/06/2024 |
Postes actifs de Harriet de Wit
| Sociétés | Poste | Début |
|---|---|---|
| PHARMALA BIOTECH HOLDINGS INC. | Directeur/Membre du Conseil | 21/03/2021 |
| The University of Chicago | Corporate Officer/Principal | - |
Pharmala Biotech, Inc.
 Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | Directeur/Membre du Conseil | - |
Formation de Harriet de Wit
| University of Calgary | Undergraduate Degree |
| Concordia University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PHARMALA BIOTECH HOLDINGS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Pharmala Biotech, Inc.
Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | Health Technology |
